Chlorpromazine Injectable Solution

Form: Injectable Solution (IM/IV)

Strength: 25 mg/mL

Reference Brands: Largactil® (EU); Thorazine®(US)

Category: Antipsychotropic Drugs

Chlorpromazine injectable solution is FDA-approved in the United States for treating severe psychotic disorders, acute agitation, intractable hiccups, and as a preoperative sedative. In the EU, it is authorized in certain countries under national procedures for similar indications, primarily in emergency psychiatric and perioperative settings. Regulatory requirements include compliance with GMP standards, stability data, and safe parenteral use documentation. U.S. filings must follow strict labeling and pharmacovigilance guidelines due to risks such as hypotension and extrapyramidal symptoms. To explore dossier-ready Chlorpromazine injectable solutions and related formulations, visit Pharmatradz.com — your trusted global B2B pharma sourcing partner.